Retrieve available abstracts of 6 articles: HTML format
Single Articles
February 2025
LI Y, Marks SM, Beeler Asay GR, Winston CA, et al Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment
of Latent Tuberculosis Infection Among the Medicare Population in 2022.
Ann Intern Med. 2025 Feb 7. doi: 10.7326/ANNALS-24-00870. PubMedAbstract available
NACHMAN A, Chagla Z In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable
status vs. a control regimen at 132 wk.
Ann Intern Med. 2025;178:JC19. PubMedAbstract available
April 2024
LI Y, Regan M, Swartwood NA, Barham T, et al Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born
Population in the United States, 2011 to 2021 : An Analysis of National Disease
Registry Data.
Ann Intern Med. 2024 Apr 2. doi: 10.7326/M23-2975. PubMedAbstract available
CASTRO KG, Shah NS Beyond the Bacillus: Closing Gaps in Tuberculosis Health Disparities Requires
Targeting Social Determinants.
Ann Intern Med. 2024 Apr 2. doi: 10.7326/M24-0548. PubMed
June 2023
SACKS HS In TB, an 8-wk, 5-drug regimen was noninferior to a standard 24-wk, 4-drug
regimen for clinical outcomes at 96 wk.
Ann Intern Med. 2023;176:JC64. PubMedAbstract available
March 2023
CONTAG CA, Maloney N, Tayyar R, Aleshin MA, et al Erythema Gyratum Repens Secondary to Pulmonary Tuberculosis.
Ann Intern Med. 2023 Mar 14. doi: 10.7326/L22-0453. PubMed